Shweta Urva

12PUBLICATIONS
26CO-AUTHORS
Behavioural epidemiologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 06, 2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Kieren J Mather, Andrea Mari, Govinda Weerakkody

|Jul 08, 2024
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker

|Feb 26, 2024
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide.

Shweta Urva, Joshua A Levine, Karen Schneck

|Feb 15, 2024
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide.

Karen Schneck, Shweta Urva

|Jun 08, 2022
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.

Shweta Urva, Tonya Quinlan, John Landry

Pageof 2